MEDIPOST Files IND for Phase 3 of Umbilical Cord Blood Stem Cell Product, Cartistem, in USA for Knee Osteoarthritis
Building on its momentum in the East, MEDIPOST received a Phase 2 waver, and is heading right for Phase 3 in the US this year. This is one to watch.